Cart
sales@molnova.com
Tyrosine kinase-IN-1
CAS No. 705946-27-6
Tyrosine kinase-IN-1( —— )
Catalog No. M20206 CAS No. 705946-27-6
Tyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor(KDR Flt-1 FGFR1 and PDGFRα with IC50s of 4nM 20nM 4nM 2 nM respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 222 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 494 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyrosine kinase-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor(KDR Flt-1 FGFR1 and PDGFRα with IC50s of 4nM 20nM 4nM 2 nM respectively).
-
DescriptionTyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor（KDR Flt-1 FGFR1 and PDGFRα with IC50s of 4nM 20nM 4nM 2 nM respectively）.
-
In VitroTyrosine kinase-IN-1 is from reference (compound 8K).
-
In VivoTyrosine kinase-IN-1 shows a reasonable PK profile (AUC(0–∞)=1.9, t1/2=4.6 h). It has a favorable oral bioavailability (F=63%) in rats.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorKDR|Flt-1|FGFR1|PDGFRα|PDGFRα
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number705946-27-6
-
Formula Weight445.54
-
Molecular FormulaC26H28FN5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (160.47 mM)
-
SMILESCCN1CCC(CC1)Nc1ccc2NC(=O)\C(=C(/c3ncc(C)[nH]3)c3cccc(F)c3)c2c1
-
Chemical Name(Z)-5-((1-ethylpiperidin-4-yl)amino)-3-((3-fluorophenyl)(5-methyl-1H-imidazol-2-yl)methylene)indolin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moon K et al. The design synthesis and biological evaluation of potent receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 22 (2012) 4979–4985
molnova catalog
related products
-
Ranibizumab
Ranibizumab is an antibody fragment without the Fc portion and affinity-matured to more strongly bind VEGF-A.
-
Pamufetinib mesylate
Pamufetinib mesylate (TAS-115 mesylate) is a potent vascular endothelial growth factor receptor (VEGFR) antagonist and hepatocyte growth factor receptor (c-Met) inhibitor used in the study of cancer and respiratory diseases.
-
Regorafenib
A potent multikinase inhibitor that potently inhibits these endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).
